TrialThe journal of prevention of Alzheimer's disease

Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer's Disease.

D Kellar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.